Informed Skin›Benzoyl Peroxide

Products

Benzoyl Peroxide

Benzoyl peroxide (BPO)

Antibacterial OTC acne treatment with no resistance risk

Acne
Safe for skin types
Safe forFitzpatrick I–III
Use cautionFitzpatrick IV–V: dryness and irritation from BPO can trigger PIH; use 2.5% concentration and moisturise
Avoid ifFitzpatrick VI: PIH risk from irritation is high; salicylic acid is generally preferred

Benzoyl peroxide is a potent oxidant that frequently causes dryness and irritation. In darker skin types, even mild BPO irritation can result in hyperpigmentation that outlasts the original acne. Lower concentrations (2.5%) perform equally to higher ones with significantly less irritation.

In plain English

Benzoyl peroxide kills the acne-causing bacteria inside your pores without causing antibiotic resistance, which is its major advantage over antibiotic acne treatments. It is FDA-approved, widely recommended by dermatologists, and available over the counter. The main downsides are bleaching fabric and hair, and causing dryness and irritation, especially at higher concentrations. At 2.5%, it works as well as 10% with significantly less side effects.

Top-rated products

Sourced via EWG Skin Deep, one of the scientific databases used by the Yuka app to evaluate cosmetic ingredient safety.

Acne Foaming Wash 10%

PanOxyl

On-the-Spot Acne Treatment 2.5%

Neutrogena

Effaclar Duo Acne Spot Treatment

La Roche-Posay

The science

Benzoyl peroxide (BPO) is an antimicrobial oxidant that releases free oxygen radicals inside the follicle, killing Cutibacterium acnes (formerly P. acnes) by oxidative damage to bacterial cell membranes and metabolic enzymes. Unlike antibiotics, it does not induce antimicrobial resistance, making it a uniquely durable long-term acne treatment. It is FDA Category I (safe and effective) OTC for acne at 2.5% to 10%, and is used in prescription combination products with clindamycin (BenzaClin, Duac) and adapalene (Epiduo/Proactiv). Efficacy is largely concentration-independent above 2.5%, while irritation increases significantly with concentration.

Why these scores
Medical PromiseHigher is better
9/10

FDA Category I for OTC acne. Extensive RCT evidence for inflammatory acne lesion reduction. No resistance development over decades of widespread use. The gold-standard antimicrobial for acne combined with adapalene in the most evidence-backed OTC acne combination.

Short-term SafetyHigher is safer
6/10

Moderate. Erythema, dryness, and peeling are common, particularly at concentrations above 2.5%. Bleaches fabric and hair on contact (irreversible). Rare but documented allergic contact dermatitis. Photosensitisation is mild.

Long-term SafetyHigher is safer
8/10

Good long-term profile for acne treatment. No systemic toxicity at topical doses; minimal systemic absorption. Some theoretical concern about oxidative stress from chronic free radical generation on skin, but no clinical evidence of long-term harm at OTC concentrations. No carcinogenicity signal in humans at cosmetic doses.

Should You Try ThisHigher is better
7/10

The most effective OTC antimicrobial for inflammatory acne. Use 2.5% rather than 10% for equivalent efficacy and significantly less irritation. Start every other day to build tolerance. Do not combine with tretinoin on the same application (BPO oxidises tretinoin).

Common misconceptions
✕Myth

“Higher concentration benzoyl peroxide works better.”

✓Reality

Multiple RCTs confirm 2.5% produces equivalent acne reduction to 5% and 10%, while 10% produces significantly more irritation and barrier damage. Dermatologists typically recommend starting at 2.5% and reserving higher concentrations for patients who truly do not respond.

✕Myth

“Benzoyl peroxide causes cancer.”

✓Reality

BPO is a free-radical generator, which raised theoretical carcinogenicity concerns. Multiple long-term safety reviews, including FDA assessments, found no evidence of carcinogenicity in humans at topical cosmetic concentrations. The FDA continues to classify it as Category I (safe and effective).

✕Myth

“Benzoyl peroxide and tretinoin can be used together in the same routine.”

✓Reality

BPO oxidises tretinoin, degrading it and reducing its efficacy. They should not be applied at the same time. The standard approach is BPO in the morning and tretinoin at night, or alternating nights, to avoid degradation.

What the evidence firmly supports
  • ✓

    Benzoyl peroxide 2.5% produces equivalent acne lesion reduction to 10% in multiple head-to-head RCTs, with significantly less dryness and irritation (Leyden et al., J Am Acad Dermatol 1987).

  • ✓

    BPO combined with adapalene (Epiduo) is the highest-evidence OTC combination for inflammatory and comedonal acne, with multiple Phase 3 trials confirming superiority over either agent alone.

  • ✓

    No documented development of C. acnes resistance to benzoyl peroxide across decades of widespread use, in contrast to topical and systemic antibiotic acne treatments.

  • ✓

    BPO reduces antibiotic-resistant C. acnes when used alongside topical antibiotics, which is why combination products (BenzaClin) include it specifically to prevent resistance.

Still being studied
  • ?

    Whether chronic oxidative stress from daily BPO application on skin has any cumulative effect on keratinocyte DNA over years of use.

  • ?

    Optimal concentration for different acne types: whether 5% or 10% provides any additional benefit over 2.5% for specific severe subtypes.

  • ?

    BPO microbiome effects: what happens to the overall skin microbiome (not just C. acnes) with long-term daily use.

  • ?

    Whether BPO formulation type (gel, cream, wash) affects efficacy independently of concentration and contact time.

Key Study

Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris

Sagransky, Yentzer & Feldman · Expert Opinion on Pharmacotherapy · 2009

BPO at 2.5%, 5%, and 10% concentrations all significantly reduce P. acnes counts. Unlike topical antibiotics, BPO does not cause bacterial resistance. Meta-analyses confirm efficacy for both inflammatory and non-inflammatory acne; irritation and bleaching of fabrics are the primary side effects.

PubMed ↗  PMID 40730431
Products on the market
BrandManufacturerWhat differentiates itApprovalPricing
Epiduo Gel (adapalene 0.1% + BPO 2.5%)GaldermaFDA-approved combination with adapalene; the most evidence-backed OTC acne combination product, now available OTC in the US2008 (Rx); OTC$35–$50 / 45 g
PanOxyl 2.5% Acne Creamy WashChattem2.5% BPO cleanser; gentlest concentration, widely recommended as a starting point and for sensitive skinOTC$12 / 170 g
PanOxyl 4% Acne Creamy WashChattem4% BPO wash; moderate concentration for those who find 2.5% insufficient for inflammatory acneOTC$13 / 170 g
Proactiv+ Skin Smoothing Exfoliator (BPO 2.5%)Guthy-Renker2.5% BPO in a subscription three-step system; includes adapalene step; effective for mild to moderate acneOTC$30–$40 / month subscription
Benzac AC 5% GelGalderma5% BPO in a water-based gel; mid-range concentration, widely available internationallyOTC$15 / 60 g
Quick Facts
DurationDaily use; acne reduction visible in 4–8 weeks
Studies400+
FDA StatusOTC Drug (US FDA Category I); OTC Cosmetic (EU varies by concentration)
Price$6–$25 / product
Full list of studies reviewed
6 studies +
  1. 1.Ho ET, et al. A randomized, double-blind, controlled comparative trial of the anti-aging properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin 0.025%. Journal of drugs in dermatology : JDD. 2012.PMID 22206079 ↗
  2. 2.Kircik LH, et al. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris. Journal of drugs in dermatology : JDD. 2012.PMID 22648221 ↗
  3. 3.Kaczvinsky JR, et al. Practical application of genomics to the development of a topical cosmetic anti-aging regimen. Skin therapy letter. 2011.PMID 21833464 ↗
  4. 4.Kim KH, et al. Chemical stability and in vitro and clinical efficacy of a novel hybrid retinoid derivative, bis-retinamido methylpentane. International journal of pharmaceutics. 2015.PMID 26325317 ↗
  5. 5.McDaniel DH, et al. Efficacy and tolerability of a double-conjugated retinoid cream vs 1.0% retinol cream or 0.025% tretinoin cream in subjects with mild to severe photoaging. Journal of cosmetic dermatology. 2017.PMID 28762645 ↗
  6. 6.Siddiqui Z, et al. Comparing Tretinoin to Other Topical Therapies in the Treatment of Skin Photoaging: A Systematic Review. American journal of clinical dermatology. 2024.PMID 28762645 ↗

Should You Try This?

15107OUT OF 10

Probably okay to try

Clinic checklist

Universal

  • Check the ingredient is listed in the first half of the INCI list to confirm meaningful concentration.
  • Look for airtight or opaque packaging -- light and air degrade active ingredients.
  • Check the expiry date before purchasing; actives degrade after opening.
  • Patch test on your inner arm for 24 hours before applying to your face.
  • Introduce one new active at a time so you can identify any reaction.
  • Store opened products away from direct sunlight and humidity.

Procedure-specific

  • Start with 2.5% rather than 5% or 10%; efficacy is equivalent and irritation is significantly lower.
  • BPO bleaches fabric and hair on contact; use white pillowcases and towels, and allow product to dry before contact with fabric.
  • Apply in the morning; pair with a ceramide moisturiser to reduce dryness and barrier disruption.
  • Do not apply on the same night as tretinoin; BPO degrades tretinoin by oxidation. Use them in opposite AM/PM slots.
  • If using alongside a topical antibiotic (clindamycin, erythromycin), BPO in the same step or routine is recommended to prevent antibiotic resistance from developing.

Educational content only. This page summarises published clinical research and is not medical advice. Consult a qualified healthcare provider before making decisions about your care.

Researched by

Val Yermakova

Informed Girl · informedgirl.com